secwatch.observer — SEC 8-K summary
======================================

Issuer:     KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS)
CIK:        0001877184
Form:       8-K
Filed at:   2025-12-01T23:59:59+00:00
Accession:  0001193125-25-303104
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Kestra Medical preliminary Q2 FY26 revenue up 52% YoY to $22.2-22.6M; gross margin improves to 50.0%
--------------------------------------------------------------------------------

- Revenue expected $22.2-$22.6M vs $14.7M prior year (+52% at midpoint).
- Gross profit $11.0-$11.4M (prior $5.8M); gross margin 50.0% vs 39.6%.
- Loss from operations $31.6-$32.0M (prior year $19.1M), reflecting investment in growth.
- Cash and equivalents ~$175M.
- CEO cites commercial momentum and positive unit economics.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525303104/0001193125-25-303104-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877184/000119312525303104/d944376d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-303104

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer